EVO (Evotec AG) Gross Profit Margin

The gross profit margin chart on GURU.Markets illustrates the performance of Evotec SE, which is developing the PanOmics AI system and Just-Evotec biomanufacturing. Business stability relies on long-term partnerships with pharma behemoths, while the 13.20 indicator expresses the state of the metric. However, reduced startup investment in early-stage development and the risk of contract terminations create certain financial threats.
Financial and market metric breakdowns for Evotec AG (EVO)

For Evotec SE, gross margin serves as an indicator of operational efficiency, reflecting the share of profit remaining after covering direct costs for preclinical research and ESG optimization of laboratories. By analyzing historical gross margin, an investor assesses the company's ability to balance costs related to bioethics and the environmental disposal of reagents, determining the business's real financial cushion before accounting for administrative expenses.